leucovorin calcium / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 424 Diseases   807 Trials   807 Trials   14372 News 


«12...220221222223224225226227228229230...235236»
  • ||||||||||  Trial termination, Metastases:  FOLFIRINOX in Patients With Inoperable Pancreatic Cancer (clinicaltrials.gov) -  Dec 8, 2013   
    P2,  N=25, Terminated, 
    Not yet recruiting --> Recruiting Recruiting --> Terminated; The principal investigator terminated the study due to inactivity and low enrollment
  • ||||||||||  Avastin (bevacizumab) / Roche
    New P3 trial, Metastases:  AXEPT: A Phase III Study of 2nd-line XELIRI  (clinicaltrials.gov) -  Nov 25, 2013   
    P3,  N=600, Recruiting, 
  • ||||||||||  Erbitux (cetuximab) / Eli Lilly
    Trial completion, Metastases:  FLOX + Cetuximab (Erbitux (clinicaltrials.gov) -  Nov 25, 2013   
    P2,  N=152, Completed, 
    Not yet recruiting --> Recruiting Recruiting --> Completed
  • ||||||||||  telisotuzumab (h224G11) / AbbVie
    Enrollment change, Metastases:  Study of ABT-700 in Subjects With Advanced Solid Tumors (clinicaltrials.gov) -  Nov 19, 2013   
    P1,  N=124, Recruiting, 
    Not yet recruiting --> Recruiting N=73 --> 124
  • ||||||||||  Avastin (bevacizumab) / Roche
    Trial completion, Metastases:  Oxaliplatin and Bevacizumab (Avastin (clinicaltrials.gov) -  Oct 31, 2013   
    P3,  N=0, Completed, 
    N=88 --> 55 Active, not recruiting --> Completed
  • ||||||||||  Enrollment open, Combination therapy, IO biomarker:  Chemotherapy for Relapsed Epstein Barr Virus Associated Lymphoma (clinicaltrials.gov) -  Oct 15, 2013   
    P2,  N=26, Recruiting, 
    Active, not recruiting --> Completed Not yet recruiting --> Recruiting
  • ||||||||||  Enrollment open:  Colon Neoadjuvant FOLFOXIRI Study (clinicaltrials.gov) -  Oct 9, 2013   
    P2,  N=40, Recruiting, 
    Not yet recruiting --> Active, not recruiting Not yet recruiting --> Recruiting